NEWS
Using New Approach, Scientists Find Evidence for Cancer Stem Cells
With the help of genetic tools, researchers have identified subsets of cells that appear to drive the growth of tumors in mice. The findings, from three independent studies, provide new support for the cancer stem cell hypothesis—the idea that some tumors are sustained by self-renewing cells that give rise to all types of tumor cells. Two of the studies appeared August 1 in Nature, and the third was published on the same day in Science. Read more > >
Trial Suggests New Treatment Option for Some Women with Metastatic Breast Cancer
More research needed before use in the clinic, some scientists cautionU.S. Prostate Cancer Incidence Falls after Change in Screening Recommendations
Findings suggest that recommendations against PSA screening for older men has had an impactSingle HPV Test Predicts the Risk of Cervical Cancer for 18 Years
HPV test predicted risk more accurately than Pap testDiscovery of Fused Genes in Brain Cancer Points to Possible Treatments
Drugs that target the resulting aberrant proteins might help affected patients
COMMENTARY
A Conversation with Dr. Walter Willett about Diet and Cancer
The chair of the department of nutrition at the Harvard School of Public Health talks about how research has changed views of diet and cancer over the last 40 years.
A MESSAGE TO READERS
NCI Cancer Bulletin Publication Break
The NCI Cancer Bulletin will not be published on August 21. Our next issue will be released on September 4, when we resume our usual biweekly publication schedule. If you are not yet a subscriber, please submit your e-mail address in the toolbox at the top right-hand corner to begin your free subscription.
IN DEPTH
Featured Clinical Trial: Genetically Engineered Immunotherapy for Advanced Cancer
Will genetically modified immune cells be safe and effective in patients with mesothelin-expressing cancers?
Bringing Science to Cancer Survivors: Workshop Series Reaches a Milestone
For 10 years, survivorship workshops have provided practical information
UPDATES
FDA Update
- New Drug Approved for Metastatic Colorectal Cancer
- Everolimus Approved for Treating Some Breast Cancers
- Carfilzomib Approved for Advanced Multiple Myeloma
CDC Update
- Drop in Cigarette Smoking Offset by Rise in Use of Other Forms of Smoked Tobacco
Cancer.gov Update
- New Research Tool Estimates Risk of Radiation-Related Cancers
Notes
- Fraumeni Steps Down as Director of NCI's Division of Cancer Epidemiology and Genetics
- NCI Releases New Guidelines for National Clinical Trials Network
- Procedures for Collecting Human Biospecimens Released
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
